|
시장보고서
상품코드
2084696
의료 기술 및 바이오의약품 기기 CMO/CDMO 시장 : 제품 유형별, 서비스 유형별, 기기 분류별, 지역별MedTech & Biopharma Device CMO/CDMO Market, By Product/Device Type, By Service Type, By Device Class, By Geography |
||||||
의료 기술·바이오의약품 기기 CMO/CDMO 시장은 2026년에 1,102억 2,720만 달러 규모에 달할 것으로 추정되고 있으며, 2033년까지 2,717억 5,850만 달러에 달할 것으로 예상되고 있습니다. 2026-2033년에는 CAGR 13.8%로 성장할 것으로 전망되고 있습니다.
| 리포트 범위 | 리포트 상세 | ||
|---|---|---|---|
| 기준연도 : | 2025년 | 2026년 시장 규모 : | 1,102억 2,720만 달러 |
| 과거 데이터 기간 : | 2020-2024년 | 예측 기간 : | 2026-2033년 |
| 2026-2033년 예측 기간의 CAGR : | 13.80% | 2033년 시장 규모 예측 : | 2,717억 5,850만 달러 |
전 세계 의료 기술(MedTech) 및 바이오의약품 기기용 CMO/CDMO 시장에는 높은 성장성과 혁신성을 갖춘 의료기기, 진단기기, 의약품·의료기기 복합제품, 약물전달 기기용 수탁 개발·제조 서비스는 물론, 기기 및 의료·헬스케어 용도용 수탁 개발·제조 서비스도 포함됩니다. CMO/CDMO는 아웃소싱 파트너로서 고객사의 설계, 엔지니어링은 물론 규제 대응, 제조, 포장, 물류의 통합을 지원합니다.
운영비 및 제품 개발비 절감, 제품 시장 출시 가속화, 혁신적인 신제품의 시장 진출, 그리고 전문적인 노하우 활용에 대한 수요가 증가함에 따라 제약, 의료기기, 바이오의약품 업계에서는 제품의 설계, 개발, 제조를 외부에 위탁하는 파트너 솔루션을 모색하는 움직임이 활발해지고 있습니다. 자동 주사기, 생물제제 투여 기기, 웨어러블 의료기기 및 관련 헬스케어 기기의 활용이 확대됨에 따라 의약품 개발과 투여 기기, 나아가 의약품과 기기의 결합을 포함하여 생명과학 산업 전반에 걸쳐 전략적으로 자리매김한 CMO/CDMO와의 파트너십이 요구될 것입니다.
시장 역학
전 세계 의료 기술(MedTech) 및 바이오의약품용 의료기기 CMO/CDMO 시장은 의료기기 개발 및 제조 기능의 아웃소싱이 확대되고 있는 추세에 힘입어 성장하고 있습니다. 의약품·의료기기 복합 제품, 바이오의약품 투여 기기, 그리고 의료 기술 기기를 위한 커넥티드 기기의 도입이 확대됨에 따라 많은 생명과학 기업은 시장 출시 기간, 제조 공정 및 비용 효율성을 최적화하기 위해 CMO/CDMO 역량을 확보해야 할 필요성에 직면해 있습니다.
그러나 시장에는 엄격한 규제 장벽, 번거로운 검증 절차, 고품질 보호에 드는 비용 등 많은 제약이 존재합니다. 이러한 시장 제약 요인에 더해, 공급망의 병목 현상과 틈새 제조 서비스의 생산 능력 한계가 맞물려 시장 발전에 걸림돌이 되고 있습니다. 그렇긴 하지만, 혁신적인 약물전달 장치와 웨어러블 의료 기술의 도입 확대, 그리고 신생 생명과학 기업의 전략적 아웃소싱 전환은 의료 기술 및 바이오의약품 장치 분야의 CMO/CDMO 시장에 새로운 성장 기회를 가져다줄 것입니다.
본 조사의 주요 특징
- 본 조사에서는 다양한 부문에 걸친 잠재적 수익 기회를 파악하고, 이 시장에서 매력적인 투자 제안 매트릭스에 대해 설명하고 있습니다.
- 또한 본 조사에서는 시장 촉진요인, 억제요인, 기회, 신제품 출시 및 승인, 시장 동향, 지역별 전망, 그리고 주요 기업이 채택하는 경쟁 전략에 관한 중요 인사이트도 제공하고 있습니다.
- 본 조사에서는 다음의 파라미터(기업 개요, 제품 포트폴리오, 주요 하이라이트, 재무 실적, 전략)를 바탕으로, 전 세계 의료 기술 및 바이오의약품 기기 CMO/CDMO 시장의 주요 기업 개요을 소개하고 있습니다.
- 이 보고서에서 도출된 인사이트는 각 기업의 마케팅 담당자 및 경영진이 향후 제품 출시, 제품 유형 업그레이드, 시장 확대 및 마케팅 전략에 대해 충분한 정보를 바탕으로 의사결정을 내릴 수 있도록 돕습니다.
- '세계의 의료 기술·바이오의약품 기기 CMO/CDMO 시장' 보고서는 투자자, 공급업체, 제품 제조업체, 유통업체, 신규 진입 기업, 금융 애널리스트 등 이 업계의 다양한 이해관계자를 대상으로 합니다.
- 이해관계자들은 전 세계 의료 기술·바이오의약품·의료기기 CMO/CDMO 시장 분석에 활용된 다양한 전략 매트릭스를 활용함으로써 의사결정을 원활하게 진행할 수 있을 것입니다.
목차
제1장 조사 목적과 전제조건
제2장 시장 전망
제3장 시장 역학·규제·동향 분석
제4장 세계의 의료 기술·바이오의약품 기기 CMO/CDMO 시장 : 제품·디바이스 유형별, 2021-2033년
제5장 세계의 의료 기술·바이오의약품 기기 CMO/CDMO 시장 : 서비스 유형별, 2021-2033년
제6장 세계의 의료 기술·바이오의약품 기기 CMO/CDMO 시장 : 의료기기의 분류별, 2021-2033년
제7장 세계의 의료 기술·바이오의약품 기기 CMO/CDMO 시장 : 지역별, 2021-2033년
제8장 경쟁 구도
제9장 애널리스트의 제안
제10장 참고 문헌 및 조사 방법
KSA 26.07.14MedTech & Biopharma Device CMO/CDMO Market is estimated to be valued at USD 110,227.2 Mn in 2026 and is expected to reach USD 271,758.5 Mn by 2033, growing at a compound annual growth rate (CAGR) of 13.8% from 2026 to 2033.
| Report Coverage | Report Details | ||
|---|---|---|---|
| Base Year: | 2025 | Market Size in 2026: | USD 110,227.2 Mn |
| Historical Data for: | 2020 To 2024 | Forecast Period: | 2026 To 2033 |
| Forecast Period 2026 to 2033 CAGR: | 13.80% | 2033 Value Projection: | USD 271,758.5 Mn |
The global MedTech & biopharma device CMO/CDMO market includes contract development and manufacturing services for medical devices, diagnostics, drug-device combination products, and drug delivery devices with high growth and innovation, as well as contract development and manufacturing services for devices and medical and healthcare applications. By functioning as outsourcing partners, CMOs/CDMOs help client companies design, engineer, provide and integrate regulatory, manufacturing, packaging and logistics.
The need to control operational and product development expenses, speed product to market, gain market access for new innovative products and leverage specialized know how is encouraging pharmaceutical, medical device, and biopharmaceutical industries to seek an outsourced product design, development and manufacturing partner solution. Increased usage of autoinjector devices and biologics delivery devices, wearable medicals devices, and associated healthcare devices will require partnerships with strategically positioned CMOs/CDMOs throughout the life science industry, including drug development and delivery device and drug device combinations.
Market Dynamics
The global MedTech & biopharma device CMO/CDMO market is driven by the rising level of outsourcing of device development and manufacturing functions. Adoption of drug device combination products, biologics delivery devices and connected devices for medtech devices is promoting life sciences players to attain CMO/CDMO competency to optimize time-to-market, manufacturing and cost efficiency.
However, a number of constraints are present in the market, such as stringent regulatory barriers, tedious validation process, and high-quality protection cost. These market limitations coupled with the bottlenecks in the supply chain and the limited capacity for niche manufacturing services pose hurdles to the market advancement. Nevertheless, increasing adoption of innovative drug delivery devices and wearable healthcare technologies as well as shift toward strategic outsourcing by emerging life sciences organizations will offer new opportunities for growth in MedTech & biopharma device CMO/CDMO market.
Key Features of the Study
- It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
- This study also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, market trends, regional outlook, and competitive strategies adopted by key players
- It profiles key players in the global MedTech & biopharma device CMO/CDMO market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
- Key companies covered as a part of this study include Integer Holdings Corporation, Jabil Inc., Flex Ltd., Sanmina Corporation, Phillips-Medisize, Nordson MEDICAL, West Pharmaceutical Services, Gerresheimer AG, SteriPack Group, and Nipro Corporation
- Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
- The global MedTech & biopharma device CMO/CDMO market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
- Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global MedTech & biopharma device CMO/CDMO market
Market Segmentation
- Product/Device Type Insights (Revenue, USD Mn, 2021 - 2033)
- Drug-Device Combination Products
- Medical Devices
- Diagnostics and Laboratory Devices/Equipment
- Other Product / Device Types
- Service Type Insights (Revenue, USD Mn, 2021 - 2033)
- Design Development and Engineering Services
- Contract manufacturing
- Supply Chain Management
- Quality and Regulations
- Other Value-Added Services
- Device Class Insights (Revenue, USD Mn, 2021 - 2033)
- Class I
- Class II
- Class III
- Regional Insights (Revenue, USD Mn, 2021 - 2033)
- North America
- U.S.
- Canada
- Latin America
- Brazil
- Argentina
- Mexico
- Rest of Latin America
- Europe
- Germany
- U.K.
- Spain
- France
- Italy
- Russia
- Rest of Europe
- Asia Pacific
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Middle East
- GCC Countries
- Israel
- Rest of Middle East
- Africa
- South Africa
- North Africa
- Central Africa
- Key Players Insights
- Integer Holdings Corporation
- Jabil Inc.
- Flex Ltd.
- Sanmina Corporation
- Phillips-Medisize
- Nordson MEDICAL
- West Pharmaceutical Services
- Gerresheimer AG
- SteriPack Group
- Nipro Corporation
Table of Contents
1. Research Objectives and Assumptions
- Research Objectives
- Assumptions
- Abbreviations
2. Market Purview
- Report Description
- Market Definition and Scope
- Executive Summary
- Global MedTech & Biopharma Device CMO/CDMO Market, By Product/Device Type
- Global MedTech & Biopharma Device CMO/CDMO Market, By Service Type
- Global MedTech & Biopharma Device CMO/CDMO Market, By Device Class
- Global MedTech & Biopharma Device CMO/CDMO Market, By Region
3. Market Dynamics, Regulations, and Trends Analysis
- Market Dynamics
- Impact Analysis
- Key Highlights
- Regulatory Scenario
- Product Launches/Approvals
- PEST Analysis
- PORTER's Analysis
- Market Opportunities
- Regulatory Scenario
- Industry Trends
4. Global MedTech & Biopharma Device CMO/CDMO Market, By Product/Device Type, 2021-2033, (USD Mn)
- Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022 - 2033
- Segment Trends
- Drug-Device Combination Products
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
- Medical Devices
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
- Diagnostics and Laboratory Devices/Equipment
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
- Other Product / Device Types
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
5. Global MedTech & Biopharma Device CMO/CDMO Market, By Service Type, 2021-2033, (USD Mn)
- Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022 - 2033
- Segment Trends
- Design Development and Engineering Services
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
- Contract manufacturing
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
- Supply Chain Management
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
- Quality and Regulations
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
- Other Value-Added Services
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
6. Global MedTech & Biopharma Device CMO/CDMO Market, By Device Class, 2021-2033, (USD Mn)
- Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022 - 2033
- Segment Trends
- Class I
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
- Class II
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
- Class III
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
7. Global MedTech & Biopharma Device CMO/CDMO Market, By Region, 2021 - 2033, Value (USD Mn)
- Introduction
- Market Share (%) Analysis, 2026, 2029 & 2033, Value (USD Mn)
- Market Y-o-Y Growth Analysis (%), 2022 - 2033, Value (USD Mn)
- Regional Trends
- North America
- Introduction
- Market Size and Forecast, By Product/Device Type, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Service Type, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Device Class, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Country, 2021 - 2033, Value (USD Mn)
- U.S.
- Canada
- Latin America
- Introduction
- Market Size and Forecast, By Product/Device Type, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Service Type, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Device Class, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Country, 2021 - 2033, Value (USD Mn)
- Brazil
- Argentina
- Mexico
- Rest of Latin America
- Europe
- Introduction
- Market Size and Forecast, By Product/Device Type, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Service Type, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Device Class, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Country, 2021 - 2033, Value (USD Mn)
- Germany
- U.K.
- Spain
- France
- Italy
- Russia
- Rest of Europe
- Asia Pacific
- Introduction
- Market Size and Forecast, By Product/Device Type, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Service Type, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Device Class, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Country, 2021 - 2033, Value (USD Mn)
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Middle East
- Introduction
- Market Size and Forecast, By Product/Device Type, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Service Type, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Device Class, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Country, 2021 - 2033, Value (USD Mn)
- GCC Countries
- Israel
- Rest of Middle East
- Africa
- Introduction
- Market Size and Forecast, By Product/Device Type, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Service Type, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Device Class, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Country/Region, 2021 - 2033, Value (USD Mn)
- South Africa
- North Africa
- Central Africa
8. Competitive Landscape
- Integer Holdings Corporation
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Jabil Inc.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Flex Ltd.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Sanmina Corporation
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Phillips-Medisize
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Nordson MEDICAL
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- West Pharmaceutical Services
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Gerresheimer AG
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- SteriPack Group
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Nipro Corporation
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
9. Analyst Recommendations
- Wheel of Fortune
- Analyst View
- Coherent Opportunity Map
10. References and Research Methodology
- References
- Research Methodology
- About us
